Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/13/23 20:02 | 11/10/23 | SGEN | Health | BioPrd | Biological Products, (No Diag | Epstein David R | WA | DO | CEO | 1 | S | -2,262 | 213.01 | 0 | -11 | 137 | D | |||||||||||||||
11/13/23 19:32 | 11/9/23 | SGEN | Health | BioPrd | Biological Products, (No Diag | Himes Vaughn B | WA | O | Chief Te | 8 | S.d | -10,236 | 195.02 | 0 | -52 | 188 | D | |||||||||||||||
9/22/23 19:51 | 9/21/23 | SGEN | Health | BioPrd | Biological Products, (No Diag | Dansey Roger D | WA | O | P,R,D,CM | 7 | S.d | -6,590 | 185.91 | 0 | -35 | 117 | D | |||||||||||||||
9/22/23 19:47 | 9/21/23 | SGEN | Health | BioPrd | Biological Products, (No Diag | Liu Jean I | WA | O | GC | 7 | S.d | -3,328 | 189.78 | 0 | -18 | 87 | D | |||||||||||||||
9/22/23 19:46 | 9/21/23 | SGEN | Health | BioPrd | Biological Products, (No Diag | Romp Charles R | WA | O | EVP,Comm | 6 | S | -444 | 199.41 | 0 | -2 | 70 | D | |||||||||||||||
9/22/23 19:45 | 9/21/23 | SGEN | Health | BioPrd | Biological Products, (No Diag | Simpson Todd E | WA | O | CFO | 8 | S.d | -29,527 | 183.38 | 0 | -161 | 137 | D | |||||||||||||||
8/29/23 18:22 | 8/28/23 | SGEN | Health | BioPrd | Biological Products, (No Diag | Welch Daniel G | WA | D | 6 | S.dm | -19,270 | 201.11 | 0 | -96 | 32 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |